Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine

Drug and Alcohol Dependence

Volumn 81, Issue 3, 2006, Pages 231-239

  Dürsteler MacFarland, Kenneth M ^a,b   Stohler, Rudolf ^a   Moldovanyi, Andreas ^a   Rey, Simone ^c   Basdekis, Raphaela ^d   Gschwend, Patrick ^c   Eschmann, Susanne ^c   Rehm, Jürgen ^c,e  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Institut fur Sucht und Gesundheitsforschung Zurich   (Switzerland)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Heroin maintenance treatment; Opioid dependence; Side effects

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIRETROVIRUS AGENT; BENZODIAZEPINE; CONTRACEPTIVE AGENT; DIAMORPHINE; HYPNOTIC AGENT; IRON; LAXATIVE; METHADONE; NEUROLEPTIC AGENT; OPIATE;

ADULT; APPETITE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BLEEDING; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED STUDY; DENTAL CARIES; DIARRHEA; DIZZINESS; DYSPNEA; ERECTILE DYSFUNCTION; FATIGUE; FEMALE; FRACTURE; HEADACHE; HEROIN DEPENDENCE; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MENSTRUAL IRREGULARITY; MICTURITION DISORDER; MUSCLE TWITCH; MYALGIA; NAUSEA; PAIN; PARALYSIS; PARESTHESIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEIZURE; SIDE EFFECT; SKIN PRURITUS; SKIN REDNESS; SKIN SWELLING; SWEATING; SWITZERLAND; THIRST; VISUAL IMPAIRMENT; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; COGNITION DISORDERS; FEMALE; HEALTH STATUS; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; MYOCLONUS; NARCOTICS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 31444447418     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.07.004     Document Type: Article

References (75)

1. A. Alvarez-Requejo, A. Carvajal, B. Begaud, Y. Moride, T. Vega, and L.H. Arias Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system Eur. J. Clin. Pharmacol. 54 1998 483 488
2. F. Azizi, A.G. Vagenakis, C. Longcope, S.H. Ingbar, and L.E. Braverman Decreased serum testosterone concentration in male heroin and methadone addicts Steroids 22 1973 467 472
3. G. Bammer, A. Dobler-Mikola, P.M. Fleming, J. Strang, and A. Uchtenhagen The heroin prescription debate: integrating science and politics Science 284 1999 1277 1278
4. A. Barsky, R. Saintfort, M. Rogers, and J. Borus Non-specific medication side effects and the nocebo phenomenon JAMA 287 2002 622 627
5. K.J. Belton The European Pharmacovigilance Research Group Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union Eur. J. Clin. Pharmacol. 52 1997 423 427
6. A. Büttner, G. Mall, R. Penning, and S. Weis The neuropathology of heroin abuse Forensic Sci. Int. 113 2000 435 442
7. Y.B. Challenor, R.W. Richter, B. Bruun, and J. Pearson Non-traumatic plexitis and heroin addiction JAMA 225 1973 958 961
8. S.T. Chermack, J. Roll, M. Reilly, L. Davis, U. Kilaru, and J. Grabowski Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions Drug Alcohol Depend 59 2000 43 49
9. T.J. Cicero, R.D. Bell, W.G. Wiest, J.H. Allison, K. Polakoski, and E. Robins Function of the male sex organs in heroin and methadone users New Engl. J. Med. 292 1975 882 887
10. P.J. Cushman Sexual behavior in heroin addiction and methadone maintenance. Correlation with plasma luteinizing hormone NY State J. Med. 72 1972 1261 1265
11. S. Darke, J. Sims, S. McDonald, and W. Wickes Cognitive impairment among methadone maintenance patients Addiction 95 2000 687 695
12. P.E. Davis, H. Liddiard, and T.M. McMillan Neuropsychological deficits and opiate abuse Drug Alcohol Depend 67 2002 105 108
13. N. Delanty, C.J. Vaughan, and J.A. French Medical causes of seizures Lancet 352 1998 383 390
14. K.M. Dürsteler-MacFarland, R. Störmer, E. Seifritz, I. Hug, F. Müller-Spahn, D. Ladewig, and R. Stohler Opioid-associated effects on oxygen saturation in humans Addiction 95 2000 285 287
15. I.A. Eland, K.J. Belton, A.C. van Grootheest, A.P. Meiners, M.D. Rawlins, and B.H. Stricker Attitudinal survey of voluntary reporting of adverse drug reactions Br. J. Clin. Pharmacol. 48 1999 623 627
16. R. Espejo, G. Hogben, and B. Stimmel Sexual performance of men on methadone maintenance Proc. Natl. Conf. Methadone Treat. 1 1973 490 493
17. A. Ghuran, and J. Nolan Recreational drug misuse: issues for the cardiologist Heart 83 2000 627 633
18. P.W. Gold, I. Extein, D. Pickar, R. Rebar, R. Ross, and F.K. Goodwin Supression of plasma cortisol in depressed patients by acute intravenous methadone infusion Am. J. Psychiatry 137 1980 862 863
19. D.S. Goldsmith, D.E. Hunt, D.S. Lipton, and D.L. Strug Methadone folklore: beliefs about side effects and their impact on treatment Human Org. 43 1984 330 340
20. I. Grant, K.M. Adams, A.S. Carlin, P.M. Rennick, L.L. Judd, and K. Schooff The collaborative neuropsychological study of polydrug users Arch. Gen. Psychiatry 35 1978 1063 1074
21. R.J. Greenwood Lumbar plexitis and rhabdomyolysis following abuse of heroin Postgrad. Med. J. 50 1974 772 773
22. N. Hagen, and R. Swanson Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies J. Pain Symptom Manage. 14 1997 51 58
23. P.K. Han, R. Arnold, G. Bond, D. Janson, and K. Abu-Elmagd Myoclonus secondary to withdrawal from transdermal fentanyl: case report and literature review J. Pain Symptom Manage. 23 2002 66 72
24. R. Hanbury, M. Cohen, and B. Stimmel Adequacy of sexual performance in men maintained on methadone Am. J. Drug Alcohol Abuse 4 1977 13 20
25. J. Hasford, M. Goettler, K.-H. Munter, and B. Muller-Oerlinghausen Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions J. Clin. Epidemiol. 55 2002 945 950
26. E. Hecker, and W.G. Friedli Plexus lesions, rhabdomyolysis and heroin Schweiz Med. Wochenschr. 118 1988 1982 1988
27. C. Hock, R. Störmer, K. Dürsteler, F. Müller-Spahn, D. Ladewig, and R. Stohler Heroin-induced deoxygenation of cerebral hemoglobin: monitoring by means of near-infrared spectroscopy Ann. Neurol. 45 1999 134 135
28. Hug, I., 1997. Epileptiform Activity in Opiate-Dependent Patients on Intravenous Substitution Treatment with Heroin, Morphine and Methadone. Medical Thesis in German, University of Basel, Basel.
29. D.E. Hunt, D.S. Lipton, D.S. Goldsmith, D.L. Strug, and B. Spunt "It takes your heart": the image of methadone maintenance in the addict world and its effect on recruitment into treatment Int. J. Addict. 20 1985 1751 1771
30. Johal, A., 2005. North America's First Heroin Prescription Program Introduced in Canada. Vancouver, British Columbia: Worldpress.org (http://www.worldpress.org/Americas/2054.cfm#down ).
31. J. Kantor, W.B. Bilker, D.B. Glasser, and D.J. Margolis Prevalence of erectile dysfunction and active depression: an analytic cross-sectional study of general medical patients Am. J. Epidemiol. 156 2002 1035 1042
32. H. Korin Comparison of psychometric measures in psychiatric patients using heroin and other drugs J. Abnorm. Psychol. 83 1974 208 212
33. M.J. Kreek Medical safety and side effects of methadone in tolerant individuals JAMA 223 1973 665 668
34. M.J. Kreek, and N. Hartman Chronic use of opioids and antipsychotic drugs: side effects, effects on endogenous opioids, and toxicity Ann. NY Acad. Sci. 1982 151 172
35. M.J. Kreek Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases Neurochem. Res. 21 1996 1469 1488
36. M.J. Kreek Opiate and cocaine addictions: challenge for pharmacotherapies Pharmacol. Biochem. Behav. 57 1997 551 569
37. M.J. Kreek Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine Ann. NY Acad. Sci. 909 2000 186 216
38. M.J. Kreek, G. Bart, C. Lilly, K.S. Laforge, and D.A. Nielsen Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments Pharmacol. Rev. 57 2005 1 26
39. C. Lanz, S. Dragoje, H.O. Zender, J. Schneider, J.N. Cox, and R.P. Baumann Cardiac vein thrombosis and haemorrhagic myocardial necrosis, report of a case with review of the literature Virchows Arch. 437 2000 560 563
40. N. MacDonald, L. Der, S. Allan, and P. Champion Opioid hyperexcitability: the application of alternate opioid therapy Pain 53 1993 353 355
41. S. Magura, and S.Y. Kang Validity of self-reported drug use in high-risk populations: a meta-analytical review Subst. Use Misuse 31 1996 1131 1153
42. S. Mercadante Pathophysiology and treatment of opioid-related myoclonus in cancer patients Pain 74 1998 5 9
43. M.Z. Mintzer, and M.L. Stitzer Cognitive impairment in methadone maintenance patients Drug Alcohol Depend 67 2002 41 51
44. S.M. Mirin, R.E. Meyer, J.H. Mendelson, and J. Ellingboe Opiate use and sexual function Am. J. Psychiatry 137 1980 909 915
45. A.R. Morral, D. McCaffrey, and M.Y. Iguchi Hardcore drug users claim to be occasional users: drug use frequency underreporting Drug Alcohol Depend 57 2000 193 202
46. A. Morrison, L. Elliott, and L. Gruer Injecting-related harm and treatment-seeking behaviour among injecting drug users Addiction 92 1997 1349 1352
47. J. Neiman, H.M. Haapaniemi, and M. Hillbom Neurological complications of drug abuse: pathophysiological mechanisms Eur. J. Neurol. 7 2000 595 606
48. S. Neshin Methadone maintenance treatment: dispelling myths and recovering truths NJ Med. 90 1993 850 852
49. S.K.C. Ng, J.C.M. Brust, W.A. Hauser, and M. Susser Illicit drug use and the risk of new-onset seizures Am. J. Epidemiol. 132 1990 47 57
50. D.M. Novick, B.L. Richman, J.M. Friedman, J.E. Friedman, C. Fried, J.P. Wilson, A. Townley, and M.J. Kreek The medical status of methadone maintenance patients in treatment for 11-18 years Drug Alcohol Depend 33 1993 235 245
51. T.J. Ornstein, J.L. Iddon, A.M. Baldacchino, B.J. Sahakian, M. London, B.J. Everitt, and T.W. Robbins Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers Neuropsychopharmacol. 23 2000 113 126
52. W.E. Penk, A.S. Brown, W.R. Roberts, M.P. Dolan, H.G. Atkins, and R. Robinowitz Visual memory of black and white male heroin and non-heroin drug users J. Abnorm. Psychol. 90 1981 486 489
53. A. Quattrini, A. Paggi, A. Ortenzi, R. Silvestri, F. Cianci, S. Ardito, M. Fronzoni, S. Sgriccia, and S. Mancini Neurological complications in drug dependence with special reference to the development of epileptic syndromes Riv. Patol. Nerv. Ment. 103 1982 262 270
54. J. Rehm, P. Gschwend, T. Steffen, F. Gutzwiller, A. Dobler-Mikola, and A. Uchtenhagen Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study Lancet 358 2001 1417 1423
55. T. Reisine, and G. Pasternak Opioid analgesics and antagonists J.G. Hardman A.G. Gilman L.E. Limbird Goodman and Gilman's the Pharmacological Basis of Therapeutics 1996 McGraw-Hill Inc. New York 521 555
56. R.W. Richter, J. Pearson, and B. Bruun Neurological complications of addiction to heroin Bull. NY Acad. Med. 49 1973 3 21
57. F.J. Santen, J. Sofsky, N. Bilic, and R. Lippert Mechanism of action of narcotics in the production of menstrual dysfunction in women Fertil. Steril. 26 1975 538 548
58. S.L. Satel, and E. Aeschbach The Swiss heroin trials - scientifically sound? J. Subst. Abuse Treat. 17 1999 331 335
59. C. Scheidegger, and W. Zimmerli Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland Rev. Infect. Dis. 11 1989 486 493
60. S.N. Schreiber, M.R. Liebowitz, and L.H. Bernstein Limb compression and renal impairment (crush syndrome) following narcotic and sedative overdose J. Bone Joint Surg. Am. 54 1972 1683 1692
61. M.T. Smith Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites Clin. Exp. Pharmacol. Physiol. 27 2000 524 528
62. W.R. Smith, and A.F. Wilson Guillan-Barre syndrome in heroin addiction JAMA 231 1975 1367 1368
63. H. Solomon, J. Man, J. Gill, and G. Jackson Viagra on the internet: unsafe sexual practice Int. J. Clin. Pract. 56 2002 403 404
64. E. Stamboulis, A. Psimaras, and S. Malliara-Loulakaki Brachial and lumbar plexitis as a reaction to heroin Drug Alcohol Depend 22 1988 205 207
65. R. Stoermer, J. Drewe, K. Dürsteler-MacFarland, D. Ladewig, C. Hock, F. Müller-Spahn, R. Stohler, and R. Mager Safety of injectable opioid treatment in addiction: a controlled clinical trial Biol. Psychiatry 54 2003 854 861
66. R. Stohler, K.M. Dürsteler, R. Störmer, E. Seifritz, I. Hug, J. Sattler-Mayr, F. Müller-Spahn, D. Ladewig, and C. Hock Rapid cortical hemoglobin deoxygenation after heroin and methadone injection in humans: a preliminary report Drug Alcohol Depend 15 1999 23 28
67. J. Strang, and H. Gurling Computerized tomography and neuropsychological assessment in long-term high-dose heroin addicts Brit. J. Addiction 84 1989 1011 1019
68. W. Tierney Adverse outpatient drug events - a problem and an opportunity N. Engl. J. Med. 348 2003 1587 1589
69. A. Uchtenhagen, A. Dobler-Mikola, and F. Gutzwiller Medically controlled prescription of narcotics: fundamentals, research plan, first experiences M. Rihs-Middel D. Lewis M. Läubli Loud D. Langenick-Cartwright Swiss Federal Office of Public Health: The Medical Prescription of Narcotics. Scientific Foundations and Practical Experiences 1997 Hogrefe & Huber Publisher Seattle (English edition)
70. Uchtenhagen, A., Gutzwiller, F., Dobler-Mikola, A., Steffen, T., Rihs-Middel, M. (Eds.), 1999. Prescription of Narcotics to Heroin Addicts: Main Results of the Swiss National Cohort Study. Karger, Basel.
71. W. van den Brink, M. Goppel, and J.M. van Ree Management of Opioid Dependence Curr. Opin. Psychiatry 16 2003 297 304
72. van den Brink, W., Hendriks, V.M., Blanken, P., Huijsman, I.A., van Ree, J.M., 2002. Medical co-prescription of heroin two randomized controlled trials: Central Committee on the Treatment of Heroin Addicts (CCBH). Available at: http://www.ccbh.nl/ENG/indexN4.html.
73. M. Warner-Smith, S. Darke, and C. Day Morbidity associated with non-fatal heroin overdose Addiction 97 2002 963 967
74. World Health Organization (Ed.), 1992. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization, Geneva.
75. World Health Organization, Substance Abuse Department (Ed.), 1999. Report of the External Panel on the Evaluation of the Swiss Scientific Studies of Medically Prescribed Narcotics to Drug Addicts. World Health Organization, Geneva. Available at: http://www.emory.edu/NFIA/legal/heroin/whoheroin.html.